ArticleNeurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology2026
Primary Sjogren syndrome with suspected central nervous system inflammatory involvement.
Article in Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionPrimary Sjögren's syndrome (pSS) is a chronic autoimmune disorder primarily affecting exocrine glands but frequently associated with extra glandular manifestations, including neurological involvement. Central nervous system (CNS) involvement is a rare and potentially severe manifestation of pSS, often leading to diagnostic uncertainty. We describe a case of pSS presenting with systemic manifestations and suspected CNS inflammatory involvement.
methodsWe report the clinical, laboratory, and imaging findings of a 43-year-old woman presenting with progressive focal neurological deficits and systemic symptoms. Diagnostic workup included brain MRI with magnetic resonance angiography (MRA) and vessel wall imaging (VWI), cerebrospinal fluid (CSF) analysis, autoimmune and infectious screening, and renal biopsy.
resultsBrain MRI revealed cerebral severe small vessel disease (cSVD), while MRA showed diffuse intracranial arterial irregularities, predominantly involving the vertebrobasilar circulation. VWI demonstrated vascular enhancement. Laboratory findings included high-titer antinuclear antibodies and anti-SSA/SSB positivity. Renal biopsy revealed tubulointerstitial nephritis with microangiopathic vascular changes. The overall clinical, laboratory, histopathological and imaging findings confirmed the diagnosis of pSS and suggested suggested a possible inflammatory vascular mechanism underlying the CNS involvement. The patient was treated with high-dose corticosteroids followed by rituximab.
conclusionsCNS inflammatory involvement may represent a rare manifestation of pSS and should be considered in patients with unexplained neurological symptoms and systemic autoimmune features. Advanced imaging techniques such as VWI may provide complementary informations. Early recognition and a multidisciplinary approach are essential to guide treatment and improve outcomes.
Indexed as
Identifiers
42397588What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.